Development of systemic chemotherapy starting from comparison with best supportive care: commentary on the INTEGRATE IIa phase III study.
Saved in:
| Title: | Development of systemic chemotherapy starting from comparison with best supportive care: commentary on the INTEGRATE IIa phase III study. |
|---|---|
| Authors: | Boku N; Department of Oncology and General Medicine, IMSUT Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan. |
| Source: | Journal of gastrointestinal oncology [J Gastrointest Oncol] 2026 Feb 28; Vol. 17 (1), pp. 41. Date of Electronic Publication: 2026 Jan 27. |
| Publication Type: | Editorial; Comment |
| Journal Info: | Publisher: AME Publishing Group Country of Publication: China NLM ID: 101557751 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2078-6891 (Print) Linking ISSN: 20786891 NLM ISO Abbreviation: J Gastrointest Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41816601 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of systemic chemotherapy starting from comparison with best supportive care: commentary on the INTEGRATE IIa phase III study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Boku+N%22">Boku N</searchLink>; Department of Oncology and General Medicine, IMSUT Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101557751%22">Journal of gastrointestinal oncology</searchLink> [J Gastrointest Oncol] 2026 Feb 28; Vol. 17 (1), pp. 41. <i>Date of Electronic Publication: </i>2026 Jan 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Group%22">AME Publishing Group </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101557751 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2078-6891 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220786891%22">20786891 </searchLink><i>NLM ISO Abbreviation: </i>J Gastrointest Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41816601 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/jgo-2025-aw-813 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 41 Titles: – TitleFull: Development of systemic chemotherapy starting from comparison with best supportive care: commentary on the INTEGRATE IIa phase III study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Boku N IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 02 Text: 2026 Feb 28 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2078-6891 Numbering: – Type: volume Value: 17 – Type: issue Value: 1 Titles: – TitleFull: Journal of gastrointestinal oncology Type: main |
| ResultId | 1 |